InvestorsHub Logo
Followers 32
Posts 6922
Boards Moderated 0
Alias Born 12/07/2003

Re: None

Thursday, 08/07/2014 12:19:50 PM

Thursday, August 07, 2014 12:19:50 PM

Post# of 7730
from another poster...

"The simple reason that Dr. Tefferi transferred ownership/sponsorship of MF IND 1951 to Geron is so patients would not have to wait 5 more months for FDA to lift the hold on Geron's ET IND and could begin the planning and implementation of the MF Phase II trials now under MF IND 1951, The simple reason that Dr. Tefferi also transferred the ongoing MF IST (MF Phase I) is because that trial was conducted under MF IIND 1951 that now belongs to Geron so they must also sponsor the MF IST that was planned to end in March 2014 anyway. The simple reason that IND 1951 transferred from Mayo to Dr. Tefferi to Geron is because, to the best of my understanding, FDA allows investigator to sponsor transfers not sponsor to sponsor transfers. The simple reason that the transfer occurred is because it is standard and common practice in the medical research community.

I do not think the transfer occurred because for 16 months I constantly said to Dr. Tefferi in a very whiny and annoying voice, "When can John be treated at home?" This was the equivalent of the backseat: 'are we there yet?' 'how much longer', 'why is it taking so long?' 'can you drive faster'?

Disclaimer: 100% of this post is my conjecture. However, it is based on considerable research effort piecing together public information. The same research effort that found Dr. Tefferi and his MF Imetelstat IST proof of concept trial and got John the last seat in it (Arm B). However, it is still my own amateur research and subject to error."

"evil flourishes when good people fail to act"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News